Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer
2002
Untangling the ErbB signalling network
2001 Standout
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
1998
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Comparison of Methods of Measuring HER-2 in Metastatic Breast Cancer Patients Treated With High-Dose Chemotherapy
2001
Targeted Therapy in Breast Cancer
2004
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer.
2000
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
The Prognostic Significance of c-erbB-2 Serum Protein in Metastatic Breast Cancer
1997
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
2002 Standout
RNAscope
2011 Standout
Prognostic Factors in Breast Cancer
2000
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Formation and Function of the Myofibroblast during Tissue Repair
2007 Standout
Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis
2009
Prognostic Factors in Node-Negative Breast Cancer
2002
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
2016 Standout
Cellular localisation byin situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer
1996
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Prognostic factors in early breast carcinoma
1994
Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis
2000
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Biomarkers in chronic kidney disease: a review
2011
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
The Role of Tubular Epithelial-Mesenchymal Transition in Progressive Kidney Disease
2007
Have we reached the limits for the treatment of diabetic nephropathy?
2014
EGF–ERBB signalling: towards the systems level
2006 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer
1998
Diabetic Retinopathy
2012 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Pathological prognostic factors in breast cancer
1999 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
2008
TEAD mediates YAP-dependent gene induction and growth control
2008 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
2008
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cathepsin D in primary breast carcinoma: Adverse prognosis is associated with expression of cathepsin D in stromal cells
1995
EXPRESSION OF CATHEPSIN D IN TRANSITIONAL CELL BLADDER TUMOURS
1996
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Accurate Measurement and Clinical Significance of Urinary Transforming Growth Factor-Beta<sub>1</sub>
2006
Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
2010
Hypoxic induction ofCtgfis directly mediated by Hif-1
2004
Type 2 diabetes mellitus
2015 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Stromal cell cathepsin D expression and long-term survival in breast cancer
1995
Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy
2010
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.
1994
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients
1998
The HER2 Extracellular Domain as a Prognostic and Predictive Factor in Breast Cancer
2002
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Breast cancer metastasis: markers and models
2005 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma: An immunohistochemical study
1996
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
2000
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Objective comparison of physical dysfunction after neck dissection
1985
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
2013 StandoutNobel
2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation
2005
Mechanisms of Diabetic Complications
2013 Standout
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
2015 StandoutNobel
Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF‐2 pathway
2015 StandoutNobel
Connective Tissue Growth Factor–Specific Monoclonal Antibody Therapy Inhibits Pancreatic Tumor Growth and Metastasis
2006
When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer
2001
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
Tumour-associated macrophages in breast cancer and their prognostic correlations
1998
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Regulation of angiogenesis by hypoxia-inducible factor 1
2006 StandoutNobel
Works of Stephen Weitz being referenced
Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
1993
Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients
1997
Urinary Connective Tissue Growth Factor Excretion in Patients With Type 1 Diabetes and Nephropathy
2003
Accumulation of NH2-Terminal Fragment of Connective Tissue Growth Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy
2004
Connective Tissue Growth Factor Is Increased in Plasma of Type 1 Diabetic Patients With Nephropathy
2004
A technique for preservation of spinal accessory nerve function in radical neck dissection
1982